BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 15461548)

  • 21. Pimecrolimus cream and Tacrolimus ointment in the treatment of atopic dermatitis: a pilot study on patient preference.
    Onumah N; Kircik L
    J Drugs Dermatol; 2013 Oct; 12(10):1145-8. PubMed ID: 24085050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of topically applied tacrolimus ointment in patients with moderate to severe atopic dermatitis.
    Wong WR; Tsai HJ; Hong HS
    Chang Gung Med J; 2003 Jul; 26(7):485-95. PubMed ID: 14515971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues.
    Czarnecka-Operacz M; Jenerowicz D
    J Dtsch Dermatol Ges; 2012 Mar; 10(3):167-72. PubMed ID: 21974750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis.
    McCollum AD; Paik A; Eichenfield LF
    Pediatr Dermatol; 2010; 27(5):425-36. PubMed ID: 20678096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis.
    Wollina U
    Am J Clin Dermatol; 2007; 8(3):157-73. PubMed ID: 17492844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tacrolimus: focusing on atopic dermatitis.
    Carroll CL; Fleischer AB
    Drugs Today (Barc); 2006 Jul; 42(7):431-9. PubMed ID: 16894398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pimecrolimus in dermatology: atopic dermatitis and beyond.
    Gisondi P; Ellis CN; Girolomoni G
    Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical tacrolimus: a new therapy for atopic dermatitis.
    Russell JJ
    Am Fam Physician; 2002 Nov; 66(10):1899-902. PubMed ID: 12469964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children.
    Alaiti S; Kang S; Fiedler VC; Ellis CN; Spurlin DV; Fader D; Ulyanov G; Gadgil SD; Tanase A; Lawrence I; Scotellaro P; Raye K; Bekersky I
    J Am Acad Dermatol; 1998 Jan; 38(1):69-76. PubMed ID: 9448208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Off-label Uses of Topical Pimecrolimus.
    Ladda M; Sandhu V; Ighani A; Yeung J
    J Cutan Med Surg; 2019; 23(4):442-448. PubMed ID: 31053034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long term management of childhood atopic dermatitis with calcineurin inhibitors].
    Thaçi D
    Hautarzt; 2003 May; 54(5):418-23. PubMed ID: 12719861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
    Ingram JR; Martin JA; Finlay AY
    Am J Clin Dermatol; 2009; 10(4):229-37. PubMed ID: 19489656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of topical calcineurin inhibitors in lichen planus.
    Samycia M; Lin AN
    J Cutan Med Surg; 2012; 16(4):221-9. PubMed ID: 22784514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Safety of topical tacrolimus and pimecrolimus in children with atopic dermatitis].
    Rodríguez Orozco AR; Ruiz Reyes H; Marín Hernández D
    Rev Alerg Mex; 2005; 52(4):171-6. PubMed ID: 16268186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of tacrolimus ointment 0.1% (Protopic) in atopic dermatitis: a Canadian open-label multicenter study.
    Tan J; Langley R
    J Cutan Med Surg; 2004; 8(4):213-9. PubMed ID: 16091997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.
    Chen SL; Yan J; Wang FS
    J Dermatolog Treat; 2010 May; 21(3):144-56. PubMed ID: 20394490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of pimecrolimus cream in disorders other than atopic dermatitis.
    Day I; Lin AN
    J Cutan Med Surg; 2008; 12(1):17-26. PubMed ID: 18258153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.